Overcoming Challenges in Drug Discovery with Lilly TuneLab

• TuneLab provides access to Lilly-trained AI models to help accelerate breakthrough medicines to patients
• The platform employs federated learning, a privacy-preserving approach that enables biotech developers to tap into Lilly’s AI models without directly exposing their proprietary data
• Hear real-world examples from partners using TuneLab to accelerate their drug discovery work

Speakers:

Jonathan Gilbert

Senior Director, Ecosystem Growth – TuneLab

Eli Lilly